News

Eveliqure initiates clinical safety and immunogenicity trials of its vaccine candidate against Shigellosis and ETEC in endemic populations in Bangladesh

Eveliqure Biotechnologies has announced the initiation of a Phase 1b clinical trial with ShigETEC, its vaccine candidate against shigellosis and…

Read more

What does cooking have to do with science? - Interview with new group leader Pim Huis in 't Veld

Pim Huis in ‘t Veld was born in the Netherlands and studied Molecular Life Sciences at the University of Nijmegen. He then obtained a Ph.D. in…

Read more

Prolongation of three Special Research Programs

The Special Research Program (SFB) in ‘Targeted Protein Degradation’, led by Perutz group leader Sascha Martens, was extended by the Austrian Science…

Read more

How eggs keep their messenger RNAs quiet

Human eggs can remain dormant within ovaries for decades. However, they store all the necessary machinery to launch embryonic development, including…

Read more

Decoding genome instability: New doc.funds initiative at the Perutz

Funding of €2 million from the Austrian Science Fund (FWF) has been allocated to a collaborative doc.funds initiative coordinated by Perutz group…

Read more

Artificial Intelligence cracks code of gene regulation

Organisms are built from thousands of different proteins, each of them encoded by a specific gene. For a cell type to acquire its unique identity,…

Read more
An hourglass sits on a white surface, in front of a dark grey background. Instead of sand, there is a double helix of DNA

New insights into how B cells time the duplication of their genome

In humans, two meters of DNA must be replicated and evenly shared between newly divided cells during every cell cycle. While some regions are…

Read more

Alejandro Burga (IMBA) and David Haselbach (IMP) join EMBO Young Investigator Program

Alejandro Burga, group leader at IMBA, and David Haselbach, Technology Platform Head for cryo electron microscopy at the IMP, were selected by the…

Read more

The stage is yours, DIDO!

Paralogous proteins have evolved from gene or whole genome duplications and may provide an insurance policy for deleterious mutations. Why some…

Read more

First multi-chamber heart organoids unravel human heart development and disease

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human…

Read more

Three ERC Consolidator Grants awarded to Vienna BioCenter Researchers

The European Research Council (ERC) awarded Consolidator Grants to three Vienna BioCenter group leaders, representing CeMESS, Max Perutz Labs and IMP.…

Read more

Decoding cell fate: Key mechanism in stem cell switch identified

Stem cells can differentiate to replace dead and damaged cells. But how do stem cells decide which type of cell to become in a given situation? Using…

Read more